Skip to content Skip to footer

Help Advance the Development of AFCR’s New Research Programs

Immunotherapy. Angiogenesis. Precision Medicine. Genomic Testing. Biomarkers. Therapeutic Antibody Engineering. CAR T Cell Therapy. When the Asian Fund for Cancer Research (AFCR) was founded one and half decades ago, many of these words did not exist or were never used in relation to cancer. But…

Read More

Coronavirus and Pets

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Cancer patients living with their pets may be becoming nervous because several recent news reports revealed…

Read More

YIV-906: Therapeutics—first-in-class botanical cancer platform drug

Ongoing since 2020 Company Overview Innovation: Therapeutics—first-in-class botanical cancer platform drug Targeted Cancer(s): Liver cancer Scientific Leadership: Yung-Chi Cheng, Ph.D.; Shwu-Huey Liu, Ph.D. Stage of Project: Phase II clinical trial about to commence; orphan drug designations granted by the U.S. Food and Drug Administration (FDA) Opportunity YIV-906 is a botanical cancer drug that…

Read More